Research Accelerated
PrecisionMed offers vital products and services facilitating breakthroughs in genetics, drug discovery, biomarker research, and molecular diagnostics. Accelerate research timelines with our immediately available human biological samples.
120+
Scientific Journal Citations
100%
Own Sample Rights
60+
IRB-Approved Protocols
600+
Customers Served
Biomarker Discovery
Discovering and validating biomarkers is time intensive and can consume substantial resources. Quick access to high-quality biological materials can reduce these challenges. Partner with PrecisionMed to gain access to our robust inventory of immediately available longitudinally-collected and well characterized individual samples.
Liquid Biopsy
Hopes for early and non-invasive detection of cancer has helped fuel the recent surge of advancements in liquid biopsy research.
A number of familial cancer genes with high-penetrance mutations have been identified, but the situation is far more complex since the contribution of low-penetrance genetic variants is poorly understood. Further study of tissue biology and treatment response is required, as well as new statistical and computational approaches for analysis of the genetic and signaling networks that orchestrate individual cancer susceptibility and tumor behavior. For this approach, well-annotated cancer tissue is required with liquid biopsy samples being ideal.
PrecisionMed supports liquid biopsy research by supplying paired plasma and resected tissue from solid tumors. Our samples are available and ready to ship within days, not weeks or months.
In Vitro Diagnostics
With chronic disease incidences on the rise, the demand for in vitro diagnostics has increased.
Our team at PrecisionMed understands the unique challenges and requirements of diagnostics and guarantees the quality of each of our samples. From our standardized collection procedures, storage, adherence to regulatory requirements, and quality control, we ensure our biospecimens are world-class and readily available to support your diagnostics research.
Scientific Journal Citations
Identification of longitudinally dynamic biomarkers in Alzheimer’s disease cerebrospinal fluid by targeted proteomics
Journal: Mol Neurodegener
Overview
Purchased from Bioreclamation, LLC (Hicksville, NY) (pooled cynomolgus monkey and pooled human CSF used in discovery experiments), Folio Biosciences (Columbus, OH) (individual longitudinal AD only) and PrecisionMed, Inc. (San Diego, CA) (individual longitudinal Control, MCI and AD). Details on sample collection were provided by the vendors. All donors provided informed consent for use of these studies.
Year
2014
Authors
Wildsmith, KR;Schauer, SP;Smith, AM;Arnott, D;Zhu, Y;Haznedar, J;Kaur, S;Mathews, WR;Honigberg, LA;
Link
https://molecularneurodegeneration.biomedcentral.com/articles/10.1186/1750-1326-9-22
Blood Serum Cytokines Induce Changes in Blood‐Brain Barrier Permeability and Gene Expression in an In Vitro Blood‐Brain Barrier Model
Journal: FASEB j.
Overview
Allows for the assessment of BBB permeability (transendothelial electrical resistance (TEER, Ω cm 2 )). Blood serum of secondary progressive MS patients (two men, two women) and four healthy individuals (two men, two women) were purchased from PrecisionMed
Year
2020
Authors
Ho, D;Kelly, G;
Link
https://faseb.onlinelibrary.wiley.com/doi/abs/10.1096/fasebj.2020.34.s1.05527
Diagnostic Value of Plasma Annexin A2 in Early-Stage High-Grade Serous Ovarian Cancer
Journal: Diagnostics (Basel, Switzerland)
Overview
Additional samples of patients with HGSOC (stage I-IV), benign ovarian lesions and healthy controls were obtained from the Hudson Institute of Medical Research (Clayton, Australia), Ontario Tumor Bank (Toronto, ON, Canada) and Precision Med Inc. (Solana Beach ;- Additional samples of patients with HGSOC (stage I-IV), benign ovarian lesions and healthy controls were obtained from the Hudson Institute of Medical Research (Clayton, Australia), Ontario Tumor Bank (Toronto, ON, Canada) and Precision Med Inc. (Solana Beach)
Year
2021
Authors
Lokman, NA;Ricciardelli, C;Stephens, AN;Jobling, TW;Hoffmann, P;Oehler, MK;